Preview

Experimental and Clinical Gastroenterology

Advanced search

Problems of diagnostics of functional disorders of the gastrointestinal system in comorbid patients

https://doi.org/10.31146/1682-8658-ecg-180-8-19-26

Abstract

Background. The primary diagnosis of functional and organic disorders in the gastrointestinal system is always a big problem, especially in patients with systemic diseases caused by disorders of carbohydrate metabolism, which can manifest themselves as directly the development of somatic pathology, as well as dysfunction of the Autonomous nervous system

The purpose is to study the structure of gastrointestinal diseases in patients with dysmetabolic disorders, in particular, with type 2 diabetes mellitus, the relationship of these disorders with indicators of autonomous regulation, and to evaluate the informativeness of some diagnostic methods in assessing the function of the stomach in these patients.

Material and methods. The study involved two stages. On the ground were examined 312 patients with impaired carbohydrate metabolism, with emphasis on the structure of comorbid pathology. The second phase was conducted in-depth survey of 49 patients to assess the state of processes of autonomic regulation and the functional state of the stomach. During the examination, special methods were used, such as intragastric pH-metry, gastroscintigraphy, and assessment of heart rate variability.

Results. The prevalence of diseases of the gastrointestinal tract in patients with impaired carbohydrate metabolism was very high and depended on the duration of the disease (more than 10 years in 100% of patients) and the severity of dysmetabolic disorders — in 91.5% of patients with unsatisfactory control of metabolic processes and in 25.3% of cases, if the disorders of carbohydrate metabolism were well controlled. The risk of developing concomitant pathology of digestive organs was higher in patients with multiple complications (RR=1,214, p<0.01, overweight (OR=5.37; p<0.001). Patients with disturbance of the autonomous regulation were more frequent hypersympathictonу that pursued disturbances of the acid-forming and motor-evacuation function.

Conclusion. In the pathogenesis of comorbid diseases that combine vomiting of the gastrointestinal tract and dysmetabolic disorders (disturbance of carbohydrate metabolism), the development of Autonomous neuropathy is important, which is simultaneously the cause of the progression of comorbid pathology and its consequence. The presence of Autonomous neuropathy makes it difficult to diagnose the disease and should be taken into account in the complex therapy of comorbid diseases.

About the Authors

N. N. Malyutina
Perm State Medical University named after Academician E.A. Wagner (PSMU)
Russian Federation

Natalia N. Malyutina - Head of the Department of Faculty Therapy No. 2, Occupational Pathology and Clinical Laboratory Diagnostics, associate Professor, doctor of medical Scienc,eLibrary SPIN-код 9767-7035.

614000, Perm, st. Petropavlovskaya, 26



I. A. Kurnikova
RUDN University
Russian Federation

Irina A. Kurnikova - Hematology and Clinical laboratory diagnostics, MD, PhD, Professor; eLibrary SPIN-код: 8579-9455.

6, Miklucho-Maklaya st, Moscow, 117198



G. I. Akhmadullina
Federal state budgetary educational institution of higher education "Izhevsk state medical Academy" of the Ministry of health of the Russian Federation
Russian Federation

Guzyal I. Akhmadullina - PhD, associate Professor; eLibrary SPIN-код: 4171-1245.

281, Kommunarov, Izhevsk, 426034



References

1. Lazebnik L. B., Konev Yu. V., Efremov L. I. Quantitative and qualitative assessment of polymorbidity in geriatric practice. Experimental and clinical gastroenterology. 2013, № 9, pp. 3-8.

2. Belyalov A. B. Theses of psychosomatic medicine. Rational Pharmacotherapy in Cardiology. 2017, № 1 3(2), pp. 221-228. DOI: http://dx.doi.org/10.20996/1819-6446-2017-13-2-221-228

3. Boytsov S. A., Chuchalin A. G. Dispensary monitoring of patients with chronic non-communicable diseases and patients at high risk of their development. Methodical recommendation. Moscow. 2014. 112р. http://www.gnicpm.ru. ISBN978-5-9905774-0-4.

4. Du Goff EH, Canudas-Romo V, ButtorffC, et al. Multiple chronic conditions and life expectancy: a life table analysis. Med Care. 2014, V.52(8), pp.688-94. doi:10.1097/MLR.0000000000000166.

5. Lazebnik L. B., Lychkova A. E., Mikhailova Z. F. Polymorbidity in inflammatory bowel diseases//Bulletin of experimental biology and medicine. 2012, V. 153, № 1, pp. 35-38

6. Efremov L. I., Lazebnik L. B., Konev Iu. V. Diagnosticheskaia taktika pri polimorbidnosti i logis-tika formulirovaniia diagnoza. Klin. gerontologiia. 2013; 3-4: 36-9 (in Russian)

7. Nedogoda S. V., Vertkin A. L., Naumov A. V., et al. Obesity and comorbid pathology in the practice of a polyclinic doctor. Part III: treatment of obesity and comorbid pathology. Outpatient reception. 2016, Vol. 2, No. 3 (6), pp. 31-42.

8. Fortin M., Stewart М., Poitras M.-E. et al. Systematic Review of Prevalence Studies on Multimorbidity: Toward a More Uniform Methodology. Ann. Fam. Med. 2012, № 10 (2), pp. 142-151.

9. Comorbid pathology in clinical practice. Algorithms for diagnosis and treatment. Clinical recommendations. Cardiovascular therapy and prevention. 2019, V18(1), pp. 5-66. http://dx.doi.org/10.15829/1728-8800-2019-1-5-66

10. Кlimenteva G. I., Kurnikova I. A., Kuznetsova I. A.et al. Type 2 diabetes mellitus and problems of comorbid pathology. Kuban scientific medical Bulletin. 2012, № 1 (130), pp. 81-85.

11. Cardiovascular Disease and Risk Management. ADA Position statement. 2014. Diabetes Care. 2015, № 38 (Suppl. 1), pp. S49-S57. DOI: 10.2337/dc15-S011.

12. Fitchett D., Zinman В, Wanner Ch. et al. Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial. Eur. Heart J. 2016. DOI: 10.1093/eurheartj/ehv728.

13. Osipenko M. F., Vorontsova E. S., Zhuk E. A. Gastroenterological symptoms in type 2 diabetes. Experimental and clinical gastroenterology. 2015;115(3):84-89

14. Chang J, Rayner CK, Jones KL, Horowitz M. Diabetic gastroparesis-backwardsand forwards. J Gastroenterol Hepatol. 2011. 26(Suppl 1), pp.46-57. doi:10.1111/j.1440-1746.2010.06573.

15. Chandrasekharan B, Srinivasan S. Diabetes and the enteric nervous system. Neu-rogastroenterol Motil. 2007. V.19, pp. 951-960. doi:10.1111/j.1365-2982.2007.01023.

16. Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrino lMetab Clin North Am. 2013. V. 42, pp.747-87. doi:10.1016/j.ecl.2013.06.00130.

17. Vinik AI, Erbas T. Diabetic autonomic neuropathy. Handb Clin Neurol. 2013, V.117, pp.279-294. doi:10.1016/B978-0-444-53491-0.00022-531.

18. Thornalley P. J., Kempler P. Diabetic neuropathy: Clinical problems and potential therapeutic approaches. Complications of diabetes mellitus: Pathophysiology and pathogenetically-based treatment option. Thieme Stuttgard. 2009, pp.36-44.

19. Vinik AI, Maser RE, Ziegler D. Autonomic imbalance: prophet of doom or scope for hope? Diabet Med. 2011, V.28, pp. 643-51. doi:10.1111/j.1464-5491.2010.03184.x

20. Chang J, Rayner CK, Jones KL, Horowitz M. Diabetic gastroparesis-backwards and forwards. J Gastroenterol Hepatol. 2011. 26(Suppl 1), pp.46-57. doi:10.1111/j.1440-1746.2010.06573.x

21. Sablin O. A., Grinevich V. B., Uspenskiy Yu. P., Ratnikov V. A. Functional diagnostics in gastroenterology. Educational and methodological guide. Saint Petersburg, 2002, 88 p.


Review

For citations:


Malyutina N.N., Kurnikova I.A., Akhmadullina G.I. Problems of diagnostics of functional disorders of the gastrointestinal system in comorbid patients. Experimental and Clinical Gastroenterology. 2020;(8):19-26. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-180-8-19-26

Views: 220


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)